key: cord-0983669-2yumxvtn authors: Zandifar, Atefeh; Badrfam, Rahim title: Exacerbation of psychosis accompanied by seizure and catatonia in a patient with COVID‐19: A case report date: 2020-11-30 journal: Psychiatry Clin Neurosci DOI: 10.1111/pcn.13174 sha: 1e5de7c50a6f751bc48556ad390be4fe0c81ef2d doc_id: 983669 cord_uid: 2yumxvtn nan At the time of discharge, he was being treated with the same antipsychotic drugs as before. According to some reports, COVID-19 may cause hyponatremia in some patients, which can be a cause of their psychosis. 4, 5 On the other hand, according to some reports, we may see the Capgras delusion due to central nervous system trauma associated with the effects of hyponatremia. 6 One report on COVID-19 and hyponatremia considers the possible association between COVID-19 and the syndrome of inappropriate antidiuretic hormone secretion in relation to a series of patients, and the possible related mechanisms are discussed. 7 Seizures due to cerebral edema seem likely in such conditions. 5 In our patient, manifestations such as mutism, stupor, positioning, negativism, and rigidity, which meet the criteria of catatonia, occurred following the initial recovery of the patient. Also, delirium and neuroleptic malignant syndrome were not considered for this patient due to his condition of stable vital signs, laboratory results, and normal EEG results. Catatonia has been reported in some patients with COVID-19. 8, 9 In our patient, symptoms improved shortly after he received lorazepam. The role of COVID-19 in catatonic formation still needs to be investigated, especially in terms of its possible mechanisms. 9, 10 In fact, while correcting hyponatremia and controlling the patient's seizures, catatonia was also controlled at the same time as treatment with lorazepam. The gradual improvement of hyponatremia was accompanied by the improvement of psychosis in the patient, and the patient's delusions (Capgras and persecutory) gradually became shakable before antipsychotic treatment was started. According to our knowledge, the patient referred to here is the first with COVID-19 who has presented with a series of manifestations in the form of electrolyte abnormality, exacerbation of underlying psychosis, seizure, and catatonia. Seizure in this patient occurred for the first time without a previous history. Hyponatremia was the only finding that could justify this clinical condition after all diagnostic evaluations. Given the importance of the issue, it seems that the effects of COVID-19 on the development of symptoms such as catatonia, exacerbation of underlying psychosis, and seizure should be considered with more focus. The co-occurrence of such manifestations in association with hyponatremia, as one of the possible electrolyte disturbances associated with COVID-19, in the form of seizure, Capgras and persecutory delusions, and catatonia, may be considered in the clinical evaluation of other similar COVID-19-related cases. One of the limitations of our study was the status of the patient as a psychiatric patient admitted to the psychiatric ward and the need for constant communication with other specialists in other fields for the patient's diagnostic and therapeutic management. In this situation, after requesting the desired counseling and explaining the patient's condition, the cooperation of other related specialists was obtained. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: A systematic review and meta-analysis with comparison to the COVID-19 pandemic COVID-19: Considering the prevalence of schizophrenia in the coming decades From encephalitis lethargica to COVID-19: Is there another epidemic ahead? Hyponatremia, IL-6, and SARS-CoV-2 (COVID-19) infection: May all fit together? Special medical conditions associated with catatonia in the internal medicine setting: Hyponatremia-inducing psychosis and subsequent catatonia Capgras syndrome, diarrhoea, and hyponatremia COVID-19-associated SIADH: A clue in the times of pandemic! A case of catatonia in a man with COVID-19 Catatonia in a hospitalized patient with COVID-19 and proposed immune-mediated mechanism COVID-19 catatonia-Would we even know? This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. We thank our colleagues in the internal medicine, infectious diseases, and neurology departments who played effective roles in the clinical management of this patient. No conflicts of interest to declare.